GlassScriptPhysician profile
Peter S Birnbaum
NPI 1538267042
$952.78
in general payments reported to CMS, 2019-2025
15 companies · $18.03 in 2025
The $18.03 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $222 · 2021: $89.76 · 2022: $70.62 · 2023: $53.64 · 2025: $18.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $356.62 | 2019-2022 | |
| Integra Lifesciences Corporation | $102.38 | 2019 | |
| Pacira Therapeutics, INC. | $65.12 | 2021 | |
| Stryker Corporation | $59.52 | 2020 | |
| Becton, Dickinson and Company | $58.45 | 2019 | |
| Linvatec Corporation | $46.65 | 2020 | |
| Checkpoint Surgical, INC | $45.82 | 2019-2023 | Checkpoint Stimulators |
| Globus Medical, INC. | $41.46 | 2023 | Troch Nail |
| Medartis INC. | $37.84 | 2020 | |
| Boston Scientific Corporation | $36.64 | 2022 | |
| Axogen | $29.49 | 2019 | |
| Abbott Laboratories | $24.64 | 2021 | |
| Atricure, INC. | $18.31 | 2020 | |
| Endo USA, INC. | $18.03 | 2025 | Xiaflex |
| Orthogenrx INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Birnbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.